Key result
Echocardiography and cardiac magnetic resonance showed strong correlation for assessing left ventricular mass (r = 0.8, P < 0.001), with agreement for hypertrophy ranging from 77% to 98%.
Why the study?
Does echocardiography reliably assess left ventricular mass and hypertrophy compared to cardiac magnetic resonance?
Cross-Sectional (n=146)
No
Does echocardiography reliably assess left ventricular mass and hypertrophy compared to cardiac magnetic resonance?
Answers are grounded in this paper and cite their sources.
Echocardiography provides reliable assessment of left ventricular mass and hypertrophy compared to CMR, though differences exist depending on the indexing method used.
BACKGROUND: Left ventricular mass (LVM) and hypertrophy (LVH) are important parameters, but their use is surrounded by controversies. We compare LVM by echocardiography and cardiac magnetic resonance (CMR), investigating reproducibility aspects and the effect of echocardiography image quality. We also compare indexing methods within and between imaging modalities for classification of LVH and cardiovascular risk. METHODS: Multi-Ethnic Study of Atherosclerosis enrolled 880 participants in Baltimore city, 146 had echocardiograms and CMR on the same day. LVM was then assessed using standard techniques. Echocardiography image quality was rated (good/limited) according to the parasternal view. LVH was defined after indexing LVM to body surface area, height(1.7) , height(2.7) , or by the predicted LVM from a reference group. Participants were classified for cardiovascular risk according to Framingham score. Pearson's correlation, Bland-Altman plots, percent agreement, and kappa coefficient assessed agreement within and between modalities. RESULTS: Left ventricular mass by echocardiography (140 ± 40 g) and by CMR were correlated (r = 0.8, P < 0.001) regardless of the echocardiography image quality. The reproducibility profile had strong correlations and agreement for both modalities. Image quality groups had similar characteristics; those with good images compared to CMR slightly superiorly. The prevalence of LVH tended to be higher with higher cardiovascular risk. The agreement for LVH between imaging modalities ranged from 77% to 98% and the kappa coefficient from 0.10 to 0.76. CONCLUSIONS: Echocardiography has a reliable performance for LVM assessment and classification of LVH, with limited influence of image quality. Echocardiography and CMR differ in the assessment of LVH, and additional differences rise from the indexing methods.
No takes yet. Share an insight, caveat, or question.
Armstrong et al. (2013) conducted a cross-sectional in Left ventricular hypertrophy (n=146). Echocardiography vs. Cardiac magnetic resonance (CMR) was evaluated on Correlation of left ventricular mass between echocardiography and CMR (r = 0.8, p=<0.001). Echocardiography and cardiac magnetic resonance showed strong correlation for assessing left ventricular mass (r = 0.8, P < 0.001), with agreement for hypertrophy ranging from 77% to 98%.
Synapse has enriched 10 related papers. Consider them for comparative context: